BEC » Topics » Other

This excerpt taken from the BEC 10-Q filed May 8, 2007.


On May 1, 2007, the Company entered into a revised merger agreement with Biosite® Incorporated (“Biosite”), a leading biomedical company commercializing proteomics discoveries for the advancement of medical diagnosis. Under the terms of the revised merger agreement, the Company will acquire all of Biosite’s outstanding common stock in a cash tender offer for $90.00 per share (an increase of $5.00 per share over the original merger agreement dated March 24, 2007) or approximately $1.67 billion in total on a fully diluted basis. The tender offer for Biosite’s outstanding common stock is valid until May 15, 2007. The Company has obtained commitment letters for an interim loan facility to finance the acquisition and expects to replace the interim loan facility within 90 days, using permanent financing consisting of approximately $800 million in convertible notes with the balance composed of long-term debt.


13. Business Segment Information

The Company is engaged primarily in the design, manufacture and sale of laboratory instrument systems and related products. The Company has one business segment consisting of four business groups focused on driving core product strategies. These business groups are Chemistry Systems, Cellular Systems, Immunoassay Systems, and Discovery and Automation Systems. The Company’s CEO, who is also the Company’s chief operating decision maker, evaluates the Company’s various global product portfolios on a revenue basis, and profitability is evaluated on an enterprise-wide basis due to shared infrastructures.



Table of Contents

            Three Months Ended            

March 31,

(in millions)

    2007   2006

Total revenue:


Chemistry Systems

   $     172.9          $     158.0      

Cellular Systems

  194.4         184.0      

Immunoassay Systems

  134.4         110.8      

Discovery & Automation Systems

  111.9         116.2      
   $     613.6          $     569.0      

Revenue by geographic areas:


United States

   $     331.9          $     305.0      


  281.7         264.0      
   $     613.6          $     569.0      
       March 31, 2007      December 31, 2006

Long-lived assets:


United States

    $  1,647.9          $  1,635.1      


  329.6         318.5      
    $  1,977.5          $  1,953.6      
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki